Sign in Subscribe
Highly active antiretroviral therapy

Hetero Partners with Gates Foundation to Expand Access to Affordable HIV Prevention Therapy

Strategic Insights

— 1 min read

The Gates Foundation has partnered with Hetero, a global leader in APIs and generic drug manufacturing, to supply a generic version of lenacapavir for HIV prevention. This collaboration aims to make a low-cost, twice-yearly injectable PrEP therapy accessible to millions of people at risk of HIV in low- and middle-income countries. Hetero has been a leading provider of HIV and AIDS medicines for over 20 years, supplying approximately 40% of the global demand for antiretroviral therapies.

Key Takeaways:

  • Hetero, a global leader in APIs and generic drug manufacturing, partners with the Gates Foundation to supply generic lenacapavir for HIV prevention.
  • The partnership aims to expand access to a low-cost, twice-yearly injectable PrEP therapy for millions of people at risk of HIV in low- and middle-income countries.
  • The affordable pricing model is designed to make the breakthrough preventive treatment sustainable and accessible for national health systems worldwide.
  • Hetero has been a leading provider of HIV and AIDS medicines for over 20 years, supplying approximately 40% of the global demand for antiretroviral therapies.
  • The partnership is supported by upfront funding and volume guarantees from the Gates Foundation.
  • The production of generic lenacapavir will be enabled at approximately $40 per patient per year.
  • Dr. Vamsi Krishna, Managing Director of Hetero Group of Companies, expressed the company's commitment to ensuring access to innovative HIV medicines for patients in India and other low- and middle-income countries.
  • Camber Pharmaceuticals, Hetero's parent company, has a growing portfolio of high-quality generic treatments for patients in the United States affected by HIV and AIDS.

Statistics:

  • Hetero supplies approximately 40% of the global demand for antiretroviral therapies.

Sources:

  • Camber Pharmaceuticals Inc., "Hetero is one of the world's leaders in HIV and AIDS medicine"
  • Gates Foundation, "Gates Foundation Partners with Hetero to Supply Affordable HIV Prevention Therapy"

Read more